相关实验视频

Updated: Jul 5, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

莫尔克2a变体导致基介导的神经病变,并通过恢复GHKL ATPase来挽救

Hye Yoon Chung¹, Geon Seong Lee¹, Soo Hyun Nam²

¹Graduate School of International Agricultural Technology and Institute of Green-Bio Science and Technology, Seoul National University, Kangwon 25354, Korea.

Brain : a journal of neurology

|January 16, 2024

概括

微型指2 (MORC2) 突变导致神经病变. 基因疗法针对MORC2进行向.

科学领域:

遗传学遗传学是一个
分子生物学分子生物学
神经学神经学

背景情况:

在MORC2中发生的突变与神经病变有关,例如Charcot-Marie-Tooth病2Z型.
之前的研究表明,Morc2a p.S87L小鼠由于DNA损伤而表现出神经病变和肌肉功能障碍.
对于MORC2相关的神经病变的确切病理机制和有效的治疗策略尚不清楚.

研究的目的:

为了阐明Morc2a p.S87L小鼠神经病变的主要致病因子.
研究涉及蛋白质合成缺陷和基积累的病理途径.
评估针对MORC2 GHKL ATPase域的腺相关病毒 (AAV) 中介基因疗法的治疗疗效.

主要方法:

在Morc2a p.S87L小鼠中的基因表达分析.
使用小鼠胚胎纤维细胞和具有MORC2变异的人类纤维细胞的病理途径调查.
在Mork2a p.S87L小鼠中对AAV-PHP.eB血清型基因治疗的体内评估.

主要成果:

Morc2a p.S87L突变会导致蛋白质合成缺陷,导致 Morc2a 功能丧失.
高基水平诱导细胞亡,导致神经病变.
针对MORC2 GHKL ATPase域的基于AAV的基因治疗成功地改善了小鼠的神经病变和肌肉功能障碍.

结论:

MORC2 p.S87L变异通过蛋白质合成缺陷引起基介导的神经病变.
MORC2 GHKL ATPase域是一个可行的治疗点,用于清除基基和恢复ATPase活性.
AAV基因疗法为Charcot-Marie-Tooth2Z型疾病和相关的MORC2神经病变提供了一个有前途的治疗策略.

关键词:

查科特-玛丽-牙2Z类型的牙在 GHKL ATPase 中.腺相关病毒的病毒.基因治疗的基因疗法一个基基的氧基.morc2a p.S87LL 在线阅读

更多相关视频

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

Published on: January 7, 2019

相关概念视频

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

ATP Synthase: Mechanism

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...